ArticleCombinatorial chemistry & high throughput screening2025

ITGB3 is a Novel Prognostic Biomarker and Correlates with Aberrant Methylation and Tumor Immunity in Clear Cell Renal Cell Carcinoma.

Hao-Yun Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.